The current stock price of AMS is 2.1 USD. In the past month the price decreased by -0.94%. In the past year, price decreased by -34.58%.
ChartMill assigns a technical rating of 1 / 10 to AMS. When comparing the yearly performance of all stocks, AMS is a bad performer in the overall market: 85.49% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to AMS. AMS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AMS reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS decreased by -950% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.84% | ||
| ROE | -9.97% | ||
| Debt/Equity | 0.58 |
5 analysts have analysed AMS and the average price target is 4.59 USD. This implies a price increase of 118.57% is expected in the next year compared to the current price of 2.1.
For the next year, analysts expect an EPS growth of 44.91% and a revenue growth 8.01% for AMS
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 81 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.
AMERICAN SHARED HOSPITAL SER
601 Montgomery Street, Suite 1112
San Francisco CALIFORNIA 94111 US
CEO: Raymond C. Stachowiak
Employees: 81
Phone: 14157885300
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 81 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.
The current stock price of AMS is 2.1 USD. The price increased by 0.96% in the last trading session.
AMS does not pay a dividend.
AMS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
AMS stock is listed on the NYSE Arca exchange.
AMERICAN SHARED HOSPITAL SER (AMS) will report earnings on 2026-04-02, after the market close.
The outstanding short interest for AMERICAN SHARED HOSPITAL SER (AMS) is 0.42% of its float.